Previous 10 | Next 10 |
2023-07-22 05:30:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Economic resiliency, s...
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, is reporting that an arbitration panel has found t...
2023-07-16 07:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Mid cap stocks generat...
NEW YORK, NY / ACCESSWIRE / July 10, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: American Equity Investment Life Holdi...
MORRISVILLE, N.C., July 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Hillary Bochniak as Chief Human Resources Officer, effective July 10, 2023. Ms. Bochniak joins...
2023-07-02 12:00:52 ET The tables have turned for Contract services organizations (CROs), with their toplines under pressure amid a post-pandemic drop in demand for clinical trial services worsened by biotech’s funding woes. The group offers clinical trial management services for...
2023-06-30 17:07:45 ET Summary Syneos Health received an acquisition offer from a PE consortium of c.$7.1 billion. The transaction involves an all-cash consideration of $43.00 per share, a 1.7% premium over SYNH's stock price at the time of the offer. Shareholders are yet to v...
MORRISVILLE, N.C., June 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with uMotif, a clinical trial technology company putting the patient at the center of research....
2023-05-26 07:00:26 ET FivepHusion has collaboration with Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions, and Syneos Health ( NASDAQ: SYNH ) to develop and bring a novel, enhanced chemotherapeutic p...
MORRISVILLE, N.C., May 25, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Batisha Anson to the newly created role of Global Head of Patient Diversity and Health Equity. In thi...
News, Short Squeeze, Breakout and More Instantly...
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...